Proxi Biotech ApS: Financial statements 2021
CVR: 39859211
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Proxi Biotech ApS (CVR 39859211) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 460,613 and a net result of DKK 2,349 compared with DKK 84,946 the year before. That is an increase of 36.7% compared with the year before. Equity in the 2021 report amounted to DKK -6,186. The company had 1 employee in the financial year.
- Gross Profit
- DKK 460,613
- Profit/Loss
- DKK 2,349
- Equity
- DKK -6,186
- Total Assets
- DKK 197,689
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 461 t. | 2 t. | -6 t. | 1 |
| 2020 | - | 337 t. | 85 t. | -9 t. | 1 |
| 2019 | - | 176 t. | -94 t. | -93 t. | 0 |
Official annual report
Find more companies like Proxi Biotech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Proxi Biotech ApS has published its annual report for 2020. Gross profit came to DKK 336,912, and the net result was DKK 84,946.
About Proxi Biotech ApS
Proxi Biotech ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PrOxi Biotech ApS and PrOxi Biotech IVS. The management consists of Rene Jørgensen and Aria Aminzadeh. The board consists of Sten Verland (chair), Aria Aminzadeh, Paul Jefferson Hargreaves and Per Bo Pedersen Fischer. The company is owned by Aminzadeh Holding ApS, Dr RJ Holding ApS and Century House Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK -430,820 and a net result of DKK -1,688,504 compared with DKK 426,762 the year before. Equity in the 2025 report amounted to DKK -1,712,625.